Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: India's Jubilant Pharmova Dec-Quarter Consol Net Profit Falls

Feb 4 (Reuters) - INDIA'S JUBILANT PHARMOVA:

    *  DEC-QUARTER CONSOL NET PROFIT 509.9 MILLION RUPEES VERSUS
PROFIT 3.1 BILLION RUPEES YEAR AGO
    * JUBILANT PHARMOVA DEC-QUARTER CONSOL SALES 12.98 BILLION
RUPEES
VERSUS 17.44 BILLION RUPEES YEAR AGO
    * JUBILANT PHARMOVA - EXPECT CDMO SEGMENT TO WITNESS NEAR
TERM
CORRECTION AS COVID RELATED PRODUCT DEMAND HAS  SUBSIDED
    * JUBILANT PHARMOVA - PERFORMANCE OF API BUSINESS EXPECTED
TO
NORMALIZE IN Q4 FY22
    * JUBILANT PHARMOVA - EXPECT TO INCUR CAPEX OF AROUND 5
BILLION
RUPEES IN FY22

Source text for Eikon:  ID:nBSE5P9kH1 
Further company coverage: [ ]

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Jubilant Pharmova

See all news